Patents/Assignees

NGM Biopharmaceuticals, Inc.

16 patents in portfolio

US12410251utility2025
Ilt-binding Agents and Methods of Use Thereof
0 cites
US12378312utility2025
Polynucleotides Encoding Human Beta Klotho Antibodies or Binding Fragments Thereof and Methods of Use Thereof
0 cites
US12240899utility2025
Lair-1-binding Agents and Methods of Use Thereof
0 cites
US12187796utility2025
Ilt3-binding Agents and Methods of Use Thereof
0 cites
US12180289utility2024
Binding Proteins and Methods of Use Thereof
0 cites
US12173060utility2024
Compositions and Methods of Use for Treating Metabolic Disorders
0 cites
US11845802utility2023
Combination Therapy with a Glucagon Receptor (GCGR) Antibody and an Anti-cd3 Antibody
0 cites
US11802155utility2023
Ilt-binding Agents and Methods of Use Thereof
0 cites
US11767359utility2023
C3-binding Agents and Methods of Use Thereof
0 cites
US11760802utility2023
Ilt3-binding Agents and Methods of Use Thereof
0 cites
US11732049utility2023
Methods of Reducing or Lowering Blood Glucose Levels in a Human Subject by Administering an Antibody That Specifically Binds Human Glucagon Receptor
0 cites
US11667708utility2023
Anti-human Beta Klotho Antibody or Binding Fragment Thereof and Methods of Their Use
0 cites
US11596676utility2023
Methods of Treating Nonalcoholic Steatohepatitis Comprising Administering an Anti-human Beta Klotho Antibody or Binding Fragment Thereof
0 cites
US11564972utility2023
Methods of Using Compositions Comprising Variants of FGF19 Polypeptides for Treating Primary Biliary Cirrhosis in a Subject
0 cites
US11566067utility2023
Methods of Lowering Triglyceride Levels with an Angptl8-binding Antibody or Antigen-binding Fragment Thereof
0 cites
US11548942utility2023
Methods of Treating a Wasting Syndrome, Increasing Growth Hormone Levels, and Increasing GHSR Activity with a LEAP2 Antibody
0 cites